The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous ... although you must authorize sharing with your clinic first. FDA clearance means that Dexcom can work to ensure ...

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

A first-of-its-kind blood test to detect amyloid plaques in the brain associated with Alzheimer's disease recently received ...

The test cleared by the FDA is likely to attract a much broader audience. "It's been through rigorous evaluation, and it provides guidance for prescribers on who's eligible and when the test ...

The test is for older Americans already exhibiting signs of Alzheimer's. The Food and Drug Administration (FDA) cleared the first blood test on Friday to help diagnose Alzheimer's disease.

The Food and Drug Administration cleared it for patients 55 and older ... Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET ...

The newly cleared test is intended for patients at specialized care centers who have signs and symptoms of cognitive decline, according to the FDA. The agency said the results should be ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous ... Last year, Dexcom received FDA clearance for the first over-the-counter CGM in the Stelo Glucose Biosensor ...